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Abstract.
Allopregnanolone (Allop) is a neurosteroid metabolite of progesterone. Allop modulates
cognition, specifically learning and memory, but these effects are frequently confounded by its
anxiolytic and sedative properties. We attempted to dissociate the anxiolytic effects of Allop
from its mnemonic effects by employing a pharmacological challenge with d- amphetamine.
Because previous research suggests that the effects of Allop may vary with the cognitive domain
being tested, we assessed both spatial and non-spatial memory. Spatial memory was tested in a
Morris Water Maze, and non-spatial object memory was tested on a novel discrimination task.
Allop, alone or in combination with d-amphetamine did not have any significant effects on
spatial memory. Neither Allop nor amphetamine alone affected memory of a novel object
relative to controls, but the combination of the two produced a dissociation and enhanced
performance. The results suggest that, depending on the type of memory being tested, the
sedative effects of Allop can be dissociated from mnemonic effects by co-administering a subthreshold dose of d-amphetamine.
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Dissociating Allopregnanolone Mnemonic Effects from Sedation
The psychotropic effects of neurosteroids have generated tremendous interest among the
scientific and medical community in recent years (Schüle, Eser, Baghai et al., 2011).
Neurosteroids are neuroactive metabolites of steroid hormones, which are converted from
peripheral hormone levels and are synthesized de novo in the brain in both men and women
(Zheng, 2009). Fluctuations in neurosteroids have been implicated in cognitive decline in several
neurodegenerative diseases as well as age-related memory changes (Naylor, Kilts, Hulette et al.,
2010; Noorbakhsh, Ellestad, Maingat et al., 2011; Paris, Walf & Frye, 2011; Wang, Liu, Irwin et
al., 2008). Additionally, neurosteroids may also play an important role in anxiety and mood
disorders such as depression and post traumatic stress disorder (Bernardi, Pluchino, Begliuomini
et al., 2004; Schüle, Eser, Baghai et al., 2011; Pinna & Rassmussen, 2011). It has been
suggested that some neurosteroids may provide useful treatments for a broad range of mood and
neurodegenerative disorders including age-related cognitive decline (Bernardi et al., 2004; Pinna
& Rassmussen, 2011).
In particular, the neuroactive metabolite of progesterone, Allopregnanolone (Allop)
possesses potent anxiolytic, sedative, and antiepileptic effects. The psychotropic effects of Allop
are mediated by a mechanism similar to the action of benzodiazepines, i.e. binding to the
GABAA receptor (Bitran, Shiekh, & McLeod, 1995; Brot, Akwa, Purdy et al., 1997). Like other
positive allosteric modulators of GABAA such as alcohol, barbiturates, and benzodiazepines
(Arolfo & Brioni, 1991; Brioni, Arolfo, Jerusalinsky et al., 1991), Allop has acute sedative
effects, although its effects on memory are less clear. In the past two decades, researchers have
published a variety of findings regarding the effects of Allop or progesterone on learning and
memory. A number of studies have indicated that Allop and progesterone may be detrimental to
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memory and cognition (Cuttler, Graf, Pawluski et al., 2011; Johansson, Birzniece, Lindblad et
al., 2002; Kask, Bäckström, Nilsson et al., 2008; Sun, Luine, Zhou et al., 2010; van Wingen et
al., 2007), while other studies indicate that Allop may improve certain forms of memory (Fry &
Walf, 2008; Frye, Duffy, & Walf, 2007; Frye & Lacey, 2000; Lewis, Orr, & Frick, 2008; Walf et
al., 2006).
Evidence for memory impairing effects. Many studies have reported that Allop and
progesterone impair performance on tests of learning and memory in both animals (Johansson,
Birzniece, Lindblad et al., 2002) and humans (Kask, Bäckström, Nilsson et al., 2008; van
Wingen, van Broekhoven, Verkes et al., 2007) in a dose-dependent manner. Allop inhibited
learning of a Morris Water Maze (MWM) in mice (Johansson et al., 2002), a test of spatial
memory, and acute administration of progesterone has also been found to impair spatial working
memory but not recognition memory in an object recognition task among both male and female
rats (Sun, Luine, Zhou et al., 2010). Acute administration of allopregnanolone also impaired
episodic memory performance in healthy middle-aged women, without affecting working
memory (Kask et al., 2008). However, this study, which used a two-back memory test, found a
ceiling effect on working memory performance, so it is possible that a more sensitive test could
reveal Allop-induced impairments on working memory. Furthermore, some studies have reported
increases in endogenous levels of Allop to be correlated with impaired memory performance and
subjective reports of cognitive difficulty (Cuttler, Graf, Pawluski et al., 2011). Increased Allop
serum levels have been found to be greatest in women during the third trimester of pregnancy
(Genazzani, Petraglia, Bernardi et al., 1998), corresponding to the finding of significant declines
in explicit memory in pregnant women from the second to the third trimester (Keenan, Yaldoo,
Stress et al., 1998).
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Evidence for memory enhancing effects. In contrast to aforementioned findings, several
studies have reported improvements in memory, following immediate post-training
administration of allopregnanolone and progesterone. This suggests that Allop may enhance
memory consolidation processes. Bodensteiner, Stone, & Ghiraldi (2008) found post-training
administration of progesterone to benefit spatial memory of young but not aged mice. However,
Lewis et al. (2008) reported contradictory findings of beneficial effects on spatial memory in
ovarectomized older mice, but no effects on ovarectomized middle aged mice following posttraining injection. Lewis et al. (2008) also found a beneficial effect from certain doses of
progesterone injected post-training, on object memory consolidation in both middle aged and
aged female mice. Other studies also have reported enhancement in object recognition, water
maze performance, and Y-maze tasks following administration of progesterone as well as Allop
immediately following training (Frye, Duffy, & Walf, 2007; Fry & Walf, 2008). Additionally,
Allop may enhance learning in conditioned passive avoidance tasks (Frye & Lacey, 2000; Walf
et al., 2006).
Factors affecting observation of memory effects. These seemingly contradictory
findings among different studies regarding the mnemonic effects of Allop may be the result of
several factors. Most notably, the effects on memory vary depending on both administration
timing and endogenous levels of Allop. Changes in endogenous levels of Allop fluctuate as a
factor of age, pregnancy, stress, and phase in the estrous or menstrual cycle (Genazzani,
Petraglia, Bernardi et al, 1998). These changes may reflect changes in sensitivity to Allop and
account for such differences in performance among aged versus young subjects, and fertile
versus postmenopausal and ovarectomized subjects. For example, Lewis et al. (2008) found
enhancing effects after 24 hours in middle aged and aged mice, while effects were not observed
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in the middle-aged mice after 48 hours. In addition, the effects on memory vary depending on
whether progesterone is administered alone or in combination with estrogen. Fertile women in
the luteal phase of the estrous cycle have also been found to have significantly higher levels of
circulating Allop than women in the follicular phase (Genazzani, Petraglia, Bernardi et al, 1998);
however, women in the luteal phase performed better on a sustained attention task and test of
implicit memory than women during the follicular phase. This finding may be the result of
concurrent changes in estrogen levels (Maki, Rich, & Shayna Rosenbaum, 2002). Estrogen may
enhance the conversion of progesterone to Allop, therby modulating its effects (Vongher & Frye,
1999).
Brain regions implicated in the action of Allop. Allop may exert its effects in a variety
of brain regions, particularly in the amygdala and the prefrontal cortex (Engin & Treit, 2007;
Van Wingen et al., 2007). Both of these regions are rich in GABA receptors by which Allop is
thought to exert its effects. Infusion into the amygdala and prefrontal cortex reliably produce
anxiolytic behavioral responses in animals, enhancing exploration (Engin & Treit, 2007). Allop
exhibits a similar anxiolytic profile to benzodiazepines, increasing open arm entries in the
elevated plus maze, and head-dips in the Boissier test (Modol, Darbra, & Pallares, 2011). Allop
also produces similar behavioral effects to benzodiazepines in the mirrored chamber test (Reddy
& Kulkarni, 1997). In women, progesterone administration decreased responses in the amygdala
and fusiform gyrus during memory encoding of faces; during retrieval, brain activity was
likewise decreased in the fusiform gyrus and prefrontal cortex (van Wingen et al., 2007).
Interestingly, van Wingen et al. did not find changes in hippocampal responses. Other studies
have failed to find behavioral effects of Allop in the hippocampus (Engin & Treit, 2007). For
example, hippocampal administrations of Allop failed to produce an anxiolytic response in the
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elevated-plus-maze or shock-probe test (Engin & Treit, 2007), in contrast to other GABA
agonists such as benzodiazepines. Allop may impair memory through an indirect mechanism, i.e.
disrupt the feedback between the limbic brain structures that are responsible for memory
formation and retrieval. These brain regions ordinarily provide important feedback to the
hippocampus to facilitate the selective encoding of emotionally salient information.
Sedative versus mnemonic effects. Further research is necessary to clarify the
inconsistent findings regarding the mnemonic effects of Allop and progesterone. Cognitive
sedation might be a contributing factor to the results of studies that have reported an impairing
effect of Allop on memory and learning performance. For example, intravenous infusion of
Allop has been found to increase subjective ratings of sedation and decrease saccadic eye
velocity (van Broekhoven, Backstrom, & Verkes, 2006). Although Allop acts on GABAA
receptors, it does not produce consistent behavioral effects when infused into the hippocampus
(Engin & Treit, 2007) and may not affect memory in the same manner as other GABA agonists
such as benzodiazepine and alcohol, which do produce behavioral effects when infused in the
hippocampus. Therefore, Allop’s effects on sedation and/or motivation may detrimentally affect
task performance in such studies, which might mask the observation of improvements in memory
and learning induced by Allop that have been documented in studies utilizing a post-training
administration technique (Lewis et al., 2008).
Although sedation can cause impairments in memory performance (Veselis et al., 2001),
the relative amount to which the sedative effects of Allop contribute to Allop-induced changes in
memory performance not been demonstrated, and it is not clear whether forms of memory may
be differentially impacted by the sedating properties of the neurosteroid. It is possible to
dissociate the mnemonic and sedative behavioral effects of other GABAA receptor agonists (i.e.
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benzodiazepines) using both electrophysiological techniques and pharmacological techniques
(Curran et al., 1998; Mitzner & Griffiths, 2007). Accordingly, the present study will attempt to
dissociate the anxiolytic effects of Allop from its effects on spatial and non-spatial memory. This
will be accomplished by co-administration of a central nervous system stimulant (CNS), a
paradigm that has been successful in differentiating anxiolytic versus memory effects in
benzodiazepines (Mitzner & Griffiths, 2007). The CNS stimulant d-amphetamine will be used in
attempt to reverse Allop-associated sedation. By counteracting the sedative effects of Allop, we
hope to observe the effects of Allop on memory in isolation. d-amphetamine promotes arousal by
increasing the availability of dopamine within the CNS. (Boutrel & Koob, 2004). This arousal
does not necessarily result in behavioral changes when applied at sub-threshold doses (Rabin,
Hunt, & Lee, 1987)., which is a useful strategy to minimize any potential confounding
behavioral effects resulting from d-amphetamine alone.
It is hypothesized that if Allop is directly impairing learning and memory processes in the
brain, acute administration of Allop combined with d-amphetamine should not cause a
significant change in performance from that following Allop administration alone. If Allopinduced impairments in memory performance that have been reported are caused by the sedating
effects of Allop rather than a true disruption in memory processes, than the stimulant should
reverse impairments on the one or more of the tasks and performance should be closer to saline
controls. On the other hand, if the sedating effects of Allop are masking a consolidation or recall
enhancing effect on one or more domains of memory, then administration of d-amphetamine
might allow such memory enhancing effects to be observed.
We chose to investigate both spatial and non-spatial memory to compare whether the
mnemonic effects of Allop could be dissociated, as some memory modalities may be more
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susceptible to dissociation. A control measure for anxiety was also performed to evaluate the
effects of combining Allop and d-amphetamine relative to treatment with Allop or saline, since
changes in anxiety level is known to affect memory performance.
The effects of Allop on spatial memory recall and new spatial learning were examined in
a Morris Water Maze. In this task, animals are trained to find the location of an underwater
platform in a pool, and then tested for spatial memory recall after receiving an assigned drug
treatment. Immediately after memory testing, we assessed learning of a new platform location.
To examine the potential facilitation of learning consolidation, memory of the new location was
tested for three consecutive days following the initial drug administration. By measuring
memory recall of a previously learned location as well as learning of a new location, we were
able to concurrently examine the effects of Allop on both spatial memory recall and new spatial
memory encoding. It is hypothesized that animals that receive Allop alone will perform worse
than controls, however the combination of Allop and d-amphetamine will partially or fully
reverse impairments.
A novel object recognition task was used to measure effects on non-spatial episodic
memory. In this task, animals are exposed to a single object and tested for their memory of the
object following day, after receiving an assigned drug treatment. It is hypothesized that
administration of Allop in combination with d-amphetamine and Allop will improve memory of
an object, relative to animals administered with Allop, d-amphetamine or saline controls

DISSOCIATING ALLOPREGNANOLONE MNEMONIC EFFECTS FROM SEDATION

10

Method
Subjects
Sixteen Male Sprague-Dawley rats (aged 9 months) were obtained from the animal
colony at Illinois Wesleyan University. Rats were housed in individual polycarbonate cages in
the animal care facility at Illinois Wesleyan University. Food and water were available ad
libitum. The housing room was maintained at 24˚C and the animals were kept on a 12:12 hour
light-dark cycle. All experimental protocols were first approved by the Institutional Animal Care
and Use Committee of Illinois Wesleyan University, in adherence to the standards established by
the National Institute of Health Guide for Care and Use of Laboratory Animals. One rat was
excluded from the study due to failure to learn the spatial memory task.
Surgery. Rats were anesthetized using 2% isoflurane gas, delivered continuously through
a nose cone. A heating pad was used to maintain constant body temperature. A stereotaxic
apparatus was installed to hold the skull for the duration of the procedure. The skull was exposed
along an incision, and stainless steel 22-gauge cannulae were bilaterally implanted targeting the
lateral ventricles (AP: -0.6, ML: +/- 1.6, DV: -3.4). Jeweler’s screws and cranioplastic cement
were used to secure the cannulae to the skull. A dummy cannulae was temporarily placed into
each guide cannula to maintain clearance. The animals were allowed to recover for a minimum
of 5-7 days prior to behavioral training procedures.
Drug Administration. The doses of Allop and d-amphetamine were determined based on
findings from previous research (Rabin et al., 1987). Both drugs were obtained from Sigma
Aldrich (St Louis, Missouri, USA). Allop or saline was delivered bilaterally via intracranial
ventricular (i.c.v.) infusion, and d-amphetamine was administered through intraperitoneal
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injection (i.p.) Allop was suspended in a vehicle solution of cyclodextrin 45% w/v in 0.9% saline
(5µg/µl). Rats received either vehicle and saline, Allop (10 mg i.c.v), d-amphetamine sulfate
(0.05 mg/kg i.p.), or Allop and d-amphetamine sulfate (10 mg i.c.v, 0.05 mg/kg i.p.).. An
infusion pump was used to deliver the Allop or saline treatment through the 22-gauge implanted
cannulae, which was attached by polyethylene tubing to a 10-µl syringe containing the prepared
treatment solution. The infusions were delivered at a rate of 1 µl/min. The needle was left in
place for an additional minute to promote diffusion.
Spatial Memory Task
Morris Water Maze Training. Rats were trained for 6 consecutive days to find the
location of a submerged hidden platform in the Morris Water Maze. The water maze used was a
wood and fiberglass circular basin with a white-painted interior. The tank was filled with tap
water, which was made opaque using nontoxic white watercolor paint. A black water-resistant
marker was used to draw a 5cm x 2cm black mark on the dorsal side of each animal, to facilitate
path tracking using an overhead computer-tracking device. Extra-maze cues were maintained
constant among all trials. Four trials were performed across each day of training, where each rat
was allowed to start in each of the four quadrants. A pseudorandom design was used to balance
the order of starting location. Each animal was allowed 60 seconds to locate a transparent
circular platform placed below the surface of the water. Rats were allowed to stay on the
platform for 10 seconds to facilitate spatial learning based on the position of extra-maze cues. In
between trials, the subjects dried with a towel and allowed to rest for 30 seconds in a holding
cage. If a rat failed to find the platform within 60 seconds, it was guided to the platform and
allowed to remain there for 10 seconds.
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Probe Trial Testing. Spatial memory recall was tested 24 hours after the last training
procedure. On the test day, the animals were divided into four groups in which they received
saline (N=4), d-amphetamine (N=4), Allop (N=3), or d-amphetamine + Allop (N=4). Saline or
Allop was administered via i.c.v infusion 30 minutes prior to testing, followed by an i.p.
injection of saline or d-amphetamine 15 minutes later. A probe trail was conducted after an
addition 15 minutes had lapsed since the second infusion. Here, the platform was removed from
the tank and the animal was placed in the water 180º from the preexisting location of the
platform. Swim distance and the percentage of time spent in each quadrant were measured to
gauge memory of the platform location. Swim speed was recorded as a measure of locomotor
activity.
New Learning Task. Immediately following the probe trial test for each rat, the platform
was replaced in the quadrant opposite to its original position. Each rat was trained to learn the
location of the new platform across four trials according to the training procedure previously
described. To evaluate the duration of Allop’s effect on new learning, the training procedure for
the new platform location was repeated after twenty-four hours, for three consecutive days.
Episodic Memory Task
Object Familiarization. One at a time, the subjects were placed in a square wooden arena
(50 cm wide x 50 cm long x 50 cm tall) containing a single object positioned 5 cm from the wall
in either the northeast or northwest corner of the box. Rats were placed on the opposite side of
the arena, facing the wall. The subjects were allowed to freely explore the box and the object (a
plastic yo-yo) until accumulating 30 sec of exploration time with the object, which served to
control for variability in activity (Lewis et al., 2008). Total exploration time was recorded, and
object exploration was timed separately by two experimenters. Object exploration time was
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recorded when the animals front paws made contact with the object or when its nose was within
1 cm of the object. The box and objects were cleaned with a mild disinfecting spray in between
trials, to eliminate olfactory cues.
Novel Object Recognition. Twenty-four hours after the sample phase, the subjects were
each administered the treatment they had been assigned in the spatial memory test. Drug and
control treatments were administered in the same procedure described above for the MWM, and
the animals were tested within 15 minutes of second treatment administration. In the choice
phase, two objects were placed in the same square arena, one in the northeast corner and one in
the northwest corner. Each object was positioned 5 cm from the wall of the box. One of the
objects was novel (a plastic horse), while the other was the same as the object used in the sample
phase (a plastic yo-yo). Total exploration time and total time spent with each object was recorded
by two experimenters who were blind to the drug condition of the animals. Animals were
allowed up to 30 minutes to accumulate a total of 30 seconds total exploration time divided
between two objects. Time spent with the novel object objects was compared to a chance
performance of 15 sec, reflecting 50% of exploration time spent exploring the novel object. It is
established that rats spend greater time exploring objects that are novel to them; so greater
percentage of time spent with the novel object compared to the familiar object indicates greater
episodic memory of the familiar object (Dere, Huston, & De Souza Silva, 2006). Exploration
time was defined by nose proximity being within 1 cm of the object or front paws touching.
Sitting or leaning on the object was not counted towards exploration time.
Elevated Plus Maze
In order to rule out changes in anxiety levels as a confounding factor in the memory
performance of the treatment groups, an elevated plus maze test was conducted immediately
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after the choice phase of the novel object recognition task. Each animal was placed in the center
of a four-arm maze, containing two open arms and two closed arms. Animals were allowed 5
minutes to explore closed and open arms, and video data was recorded and coded at by
experimenters who were blind to the animal’s treatment condition. Measured included number of
entries as well as total time spent in open arms, closed arms and center.

Results
The effects of allopregnanolone MWM performance and novel object recognition were
investigated in a pharmacological dissociation design (N=15). After the animals were trained in
the water maze task, a one-way ANOVA was conducted on the final-day mean swim distance to
confirm a constant level of acquisition among the groups (p>0.05). The animals were assigned to
treatment groups, and the subjects were counterbalanced to eliminate significant differences in
pre-treatment group means for swim distance on the final day of training. One animal was
excluded due to poor swimming ability and failure to learn the location of the platform following
six days of training. There were no differences among the pre-treatment group means on final
swim distance for saline + vehicle (M = 272.97, SD = 281.73) Allop (M = 240.45, SD = 87.6), damphetamine (M = 237.9, SD = 77.29), or Allop + d-amphetamine (M = 241.67, SD = 117.17).
Morris Water Maze. The effects of allopregnanolone on acute spatial memory recall
were examined alone an in combination with d-amphetamine. A two-way ANOVA without
repeated measures was used to examine the dependent variables: swim speed, total swim
distance, percent of swim distance in target quadrant, percent of time in target quadrant, entries
into target quadrant, and latency to enter the target quadrant. Statistical analysis (d-amphetamine
x Allop) revealed no significant main effects of Allop or d-amphetamine for any of the
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dependent variables examined (p>0.05) (see figures 1,2). We did not observe any Allop x damphetamine interactions for swim speed, percent of swim distance in target quadrant, percent of
swim time in target quadrant, total swim distance, latency to enter the target quadrant (p>0.05).
As such, it was not possible to dissociate the acute mnemonic and sedative effects of
allopregnanolone for spatial memory, since no impairment or improvement in memory by Allop
or d-amphetamine alone was observed in the probe trial.
The effects of allopregnanolone on new learning and memory consolidation were also
examined across a four-day water maze training procedure of a new platform location following
treatment administration. A three-way 2x2x4 ANOVA (Allop x d-amphetamine x Training Day)
was conducted examining the dependent variables: total swim distance, latency to locate the
platform, and latency to enter the target quadrant. In addition, percent of total swim distance
spent in the target quadrant (see figure 3) and in the previously learned target quadrant were
compared among the treatment groups in a three-way ANOVA. A significant main effect of
Training Day was found for total swim distance, F(1,3) = 22.34, p =.001, latency to locate
platform F(1,3) = 21.98, p =.001, percent swim distance in target quadrant F(1,3) = 81.21, p <
.001, and percent swim distance in previously learned target quadrant F(1,3) = 68.27, p < .001.
No significant main effects of Allop or d-amphetamine were observed for any of the dependent
variables listed (p>0.05). There were no significant two-way or three-way interactions between
Allop x Day, d-amphetamine x Day, or Allop x d-amphetamine x Day. A repeated-measures
ANOVA was also performed for all of the measures listed above as well as for the difference
scores for the behavioral measures between the 1st and 2nd day of learning. No significant main
effects of treatment or interactions were observed for any of the measures (p>0.05). In summary,
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we did not observe any behavioral effects of Allop, alone or in combination with d-amphetamine
on either spatial recall or new spatial learning.
Novel Object Recognition. For the object recognition task, a two-way ANOVA without
repeated measures was conducted to analyze percent of time spent with the novel object in the
choice phase among the treatment groups. A 2x2 ANOVA (d-amphetamine x Allop) for percent
of time spent with novel object revealed no main effects for d-amphetamine or allopregnanolone
(p>0.05). However, there was a significant interaction effect for percent time spent with novel
object F(1,11) = 8.43, p=.014. A one-way ANOVA followed by Tukey’s HSD post hoc test was
used to evaluate significant differences between groups’ means for the dependent variable
percent time spent with the novel object. There were no significant differences between the
means of Allop, controls, and d-amphetamine alone (p>0.05). However, there was a significant
difference between the d-amphetamine group and the Allop + d-amphetamine group q[4,11] =
4.26, p<0.05 (see figure 4). This implies that the combination of Allop + d-amphetamine resulted
in significantly improved memory of an object, relative to the performance of d-amphetamine
alone.
Elevated Plus Maze. For the elevated plus maze, a 2x2 ANOVA without repeated
measures (d-amphetamine x Allop) was performed to examine differences the anxiolytic effects
of the drug treatments. Number of entries and total time spent in closed arms, open arms, and
center platform were examined. Additionally, percent time spent in closed arms, open arms, and
center was computed and analyzed (see figure 5). Analysis revealed no significant main effects
for Allop for number of entries in open arms, closed arms, or center, as well as total time spent in
closed arms, open arms, or center. In addition, no significant main effects or interactions were
observed for number of entries into closed or open arms, (p>0.05), although there was a
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significant main effect for d-amphetamine for entries into the center of the maze F(1,11) = 8.43,
p=.048. However, a one-way ANOVA followed by Tukey’s HSD post hoc found that there were
no significant differences between any of the group means.

Discussion
A number of previous studies have examined the effects of Allop on novel object
recognition and episodic memory, and there are reports of impairment (Kask et al., 2007;
Matthews et al., 2002) and enhancement (Frye & Walf, 2008; Lewis et al., 2008; Walf et al.,
2006) across multiple domains of memory. In attempt to resolve such findings, the purpose of
this study was to dissociate the sedative and mnemonic effects of Allop. While sedation can
produce memory impairments, there is evidence that drug induced amnesia is a separate
phenomenon that can be dissociated using pharmacological and electrophysiological techniques
(Curran et al., 1998; Mitzner & Griffiths, 2006; Veselis et al., 2001). The results indicate that the
sedative effects of Allop can be dissociated from mnemonic effects differentially for spatial and
non-spatial memory. Our main finding is that the combination of Allop and d-amphetamine
interacted to improve performance of a novel object recognition task. The presence of this
interaction suggests Allop may benefit recognition memory when its sedative properties are
negated. We observed that Allop in combination with d-amphetamine produced greater
exploration of a novel object versus a familiar object. It is well established that rats spend greater
time exploring objects that are new to them (Dere et al., 2006), so greater time spent exploring a
novel object versus a familiar object indicates that the animal has a memory of the familiar
object.
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Object recognition memory is thought to be mediated primarily by the medial temporal
lobe brain structures—in particular, the perirhinal and parahippocampal cortices (Dere et al.,
2006; Winters et al., 2008). Lesions to these regions cause far greater deficits in tasks of object
recognition memory than lesions to the amygdala and the hippocampus combined (Murray &
Mishkin, 1998; Winters et al., 2008). Given that combination of Allop and d-amphetamine was
found to alter object recognition in this study, it would be interesting to repeat the procedure
infusing Allop directly into the perirhinal cortex.
In addition to investigating object memory, we also attempted to dissociate the sedative
and amnestic effects of Allop on spatial memory. Although the majority of previous studies that
examined the effects of Allop and progesterone on acute spatial memory have reported
impairments (Frye & Sturgis, 1995; Johansson et al, 2002; Mayo et al, 1993), we did not observe
any acute impairing or enhancing effects. In addition, we found no treatment effects on new
spatial learning over the course of four consecutive days following initial training of a new
platform location. All of the groups learned the task equivalently according to behavioral
measures examined. Thus, it was not possible to dissociate the mnemonic effects from sedation
in these tasks. Although the groups were balanced for spatial learning on the last day of testing,
there was variability in the probe trial performance, among all of the groups. In particular, we
observed high variability in the control group for the MWM probe trail. Consequently, we were
unable to identify specific trends in performance as a function of drug treatment. Perhaps a larger
sample would have revealed a more conspicuous pattern of results. It is also possible that the
effects of Allop on spatial memory performance in the MWM are short lived and below
impairment thresholds 30 minutes after administration when we conducted memory testing.
(Johansson et al. 2002)
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There are several limitations to this study. One important limitation is that we have not
yet confirmed the cannula placement through which the Allop or saline was delivered. Although
measurements were taken with care and pilot placements were confirmed, slight deviations in
location or angle of installation could have prevented proper delivery of Allop into the lateral
ventricles. This could potentially affect the cognitive and behavioral results in the tasks
performed. While this information would be very useful in interpreting our results, it is beyond
the scope of this project. Although we did find a significant interaction for the effects of Allop
and d-amphetamine on object recognition memory, it is also worth mentioning that the mean
baseline performance of the control animals was less than 50% for time spent with the novel
object. Lower than expected performance of the control animals due to variability may limit our
ability to make meaningful comparisons among our groups.
Although we did not examine the effects of Allop on post-training memory consolidation
in the object recognition task, there is evidence that Allop improves memory consolidation
(Escudero et al, 2012) and subsequent memory performance the following day (Lewis et al.,
2008). Future directions might include examining the effects of post-training administration of
Allop and d-amphetamine on object recognition. It would also be useful to verify the effects of
Allop in combination with d-amphetamine by examining other tests of spatial and non-spatial
memory.
Despite its sedative effects, Allop has many beneficial properties including anxiolytic and
antiepileptic effects that may make it an appealing pharmacological agent for treating a variety of
conditions including anxiety disorders, depression, epilepsy, and bipolar disorder (Bernardi et al.,
2004; Pinna & Rasmussen, 2011; Schüle et al., 2011), as a replacement or adjunct to other
current drug treatments. It is important to characterize the effects of Allop on learning and
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memory to establish whether it may be a useful alternative treatment to benzodiazepines in
anxiety disorders and Post Traumatic Stress Disorder (PTSD). Commonly prescribed
benzodiazepine treatments for generalized anxiety disorder and PTSD exert potent memory
impairing effects that have been well established (Curran et al., 1998; Mitzner & Griffiths, 2007;
Veselis, 2001); this was demonstrated in both electrophysiological dissociations and
pharmacological dissociations similar to this current study. Thus, if Allop does not directly
impair forms of memory, and its sedative effects can be reversed with a sub-threshold stimulant,
it may be preferable to drug treatments that directly affect memory. In addition, changes in
endogenous levels of Allop may play a role in post-menopausal memory decline (Paris et al.,
2011) and in certain neurodegenerative diseases such as Alzheimer’s disease (Naylor et al.,
2010; Wang et al., 2008) and Multiple Sclerosis (Noorbakhsh et al., 2011). Both of these
diseases are characterized by decreases in brain concentrations of Allop. Allop may also have
important implications in the treatment of normal age related cognitive decline (Paris et al.,
2011). Thus, it is vital to continue explorations of the role of Allop on cognitive and disease
states, which may provide improved treatment options for a wide range of disorders.
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Figure 1. Effects of drug treatments on spatial memory recall. Bars represent the effects of
Saline, Allopregnanolone, d-amphetamine, and d-amphetamine + Allopregnanolone on percent
of time spent in target quadrant in probe trial of MWM. Error bars represent +/- 1 standard error.
No significant effects of any of the treatments were observed on spatial memory recall (p>0.05).
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Figure 2. Effects of drug treatments on motor functions in the MWM. Bars represent the effects
of Saline, Allopregnanolone, d-amphetamine, and d-amphetamine + Allopregnanolone on swim
speed in target quadrant in probe trial of MWM. Error bars represent +/- 1 standard error.
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Figure 3. Effects of drug treatments on spatial new learning in male rats. Separate lines indicate
drug treatment. X-axis represents the day of testing following the initial training of a new
platform location in the MWM under the influence of allopregnanolone, d-amphetamine, saline,
or d-amphetamine + Allopregnanolone. Y-axis represents percent of swim time spent in target
quadrant. Positive slope indicates learning has occurred.
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Figure 4. Effects of drug treatments on object recognition memory in male rats. Rats received
allopregnanolone or saline, alone or combination with d-amphetamine. Bars represent mean
percent of time exploring a novel object versus a familiar object (data not shown). Error bars
represent +/- 1 standard error.
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Figure 5. Effects of drug treatments on anxiety in the Elevated Plus Maze (EPM) in male rats.
Bars represent percent of time in closed, center, and open arms of maze over 5 minutes of run
time. Greater time spent in open arms and center indicates lower levels of anxiety. Error bars
represent +/- 1 standard error.
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